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INTRODUCTION:  Phyllodes  tumor  of  the  breast  is  a  rare  cause  of  breast  cancer,  accounting  for  less  than
0.5%  of  breast  cancers.  These  tumors  are  classiﬁed  as  benign,  borderline,  or malignant,  with  malignant
tumors  compromising  nearly  25%  of  cases.  Metastases  occur  in  20%  of  malignant  tumors,  lungs,  bones,
liver  and  brain  being  the  frequent  sites  of  metastases.
PRESENTATION  OF  CASE:  We  present  a case  of  a metastatic  phyllodes  tumor  to  the small  bowel  causing
jejunal  intussusception,  symptomatic  anemia,  and  small  bowel  obstruction.
DISCUSSION:  Patients  with  phyllodes  tumor  of the  breast  can develop  disease  recurrence  even years  aftermall bowel obstruction
ntussusception
initial  treatment.  Phyllodes  tumor  metastasizing  to the  small  bowel  is  extremely  rare,  with  only  three
known  previously  described  case  reports  in  the  literature.
CONCLUSION:  High  risk  patients,  with  a past  medical  history  of phyllodes  breast  cancer,  should  be  moni-
tored  closely.  Even  years  after  breast  cancer  treatment,  these  patients  may  present  with  gastrointestinal
complaints  such  as  obstruction  or bleeding,  and  therefore  metastatic  disease  to the  small  bowel  should
be considered  on  the  differential  with  subsequent  abdominal  imaging  obtained.
gical © 2011 Sur
. Case report
Our patient is a 59-year-old African American woman, who pre-
ented to the emergency room in June of 2010 with a growing
ight breast mass for the previous six months. She denied breast
ain, nipple discharge, fever, weight loss, coughing, or abdomi-
al pain. A core needle biopsy was done, which showed a spindle
ell neoplasm with heterologous elements not associated with
ny epithelial component. There was noted moderate stromal
typia, with increased stromal cellularity, and increased stromal
itoses (up to 8 mitoses/10 HPF). Immunohistochemistry revealed
he spindle cells, to be positive for vimentin and SMA, focally pos-
tive for CD34 and negative for pancytokeratin, HMWK,  CAM5.2,
esmin, and S100.
In August of 2010, she underwent a right modiﬁed radical
astectomy, which revealed a 19 cm mass. Histopathology of
he mass showed a malignant phyllodes tumor with chondrosar-
omatous elements (grade 3) with a mitotic count score of 3
40 mitoses/10 HPF), and a necrosis score of 1 (50% tumor necrosis).
o lymphovascular invasion was identiﬁed. She did not receive anyurther adjuvant chemotherapy or radiation therapy.
On July 20th, 2011, the patient presented to the emergency room
omplaining of inability to keep food down, nausea and vomiting,
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shortness of breath, and vague epigastric pain for 2 weeks. She
was found to have microcytic anemia (hemoglobin of 6.6), and was
given two  units of packed red blood cells with resolution of her
shortness of breath. A computed tomography (CT) of the abdomen
and pelvis showed a jejunal mass as the lead point for intussuscep-
tion with surrounding mesenteric lymphadenopathy (Fig. 1). Upper
and lower endoscopies demonstrated an irregularly shaped het-
erogeneous mass in the proximal jejunum which was  brown/black
and actively bleeding. An exploratory laparotomy was  performed
and the jejunal intussusception was found 12 cm from the ligament
of Trietz with associated mesenteric lymphadenopathy. There was
no other signiﬁcant pathology on examination of the remainder of
abdominal viscera. The mass was  resected along with its mesentery
and the bowel anastamosed.
Pathologic examination of the mass revealed an
8 cm × 3.7 cm × 3.4 cm high-grade malignant neoplasm, com-
patible with metastatic malignant phyllodes tumor from the
previously diagnosed right breast primary. The metastatic lesion
showed a higher grade and no de-differentiation compared to the
previously resected breast tumor (Figs. 2 and 3).
2. Discussion
Phyllodes tumor of the breast is a rare cause of breast can-
Open access under CC BY-NC-ND license. cer, accounting for less than 0.5% of breast cancers.1 These tumors
are classiﬁed as benign, borderline, or malignant, with malignant
tumors compromising nearly 25% of cases.2–4 Metastases occur
in 20% of malignant tumors, and they generally spread to the
Y-NC-ND license. 
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[Fig. 1. CT of the abdomen showing a jejunal intussusception.
ungs, bones, liver and brain.5 Phyllodes tumor metastasizing to
he small bowel is extremely rare with only three previous cases
escribed in literature.6–8 In the ﬁrst case the patient presented
ith upper gastrointestinal bleeding and was found to have a mass
n the duodenum. In the second case the patient presented with
bdominal pain and vomiting, and a mass was found to be an
leocecal intussusception. In the third case the patient presented
ith abdominal pain, weight loss, and nausea and was  found to
ave an intraluminar lobular mass in the mid-ileum. Similarly, our
atient presented with anemia and vague abdominal complaints.
he CT ﬁndings of jejunal intussusception along with diagnostic
ndoscopy resulted in a surgical consult which ultimately led to a
iagnosis of metastatic phyllodes tumor.
ig. 2. Histology of jejunal mass. (A) H&E stained section showing the high grade
rea of the malignant phyllodes tumor in the breast exhibiting cells with pleo-
orphic hyperchromatic to vesicular nuclei and abnormal mitotic ﬁgures (arrows)
400×]. (B) Section showing the chodrosarcomatous change in the tumor (100×).
Fig. 3. Original right breast phyllodes tumor histology. (A) Photomicrograph depict-
ing the metastatic phyllodes tumor. The uninvolved small bowel mucosa is seen
to  the left (50×). (B) Higher power showing the pleomorphic hyperchromatic to
vesicular nuclei similar to high grade areas in (A) (400×).
Patients with phyllodes tumor of the breast can develop dis-
ease recurrence even years after initial treatment. The sarcoma
and phyllode retrospective (SAPHYR) retrospective study demon-
strates the impact of histological classiﬁcation on survival rates.
Three year disease-free survival rates for benign and borderline
tumors was 57%, while for malignant tumors it was  45%.9 Further-
more, metastatic phyllodes tumor can present within three years
of initial therapy or even after more than ten years.4 Therefore
high risk patients should be monitored closely. Traditionally, atten-
tion has been directed to monitoring the pulmonary, nervous, and
skeletal systems with CT imaging of the lungs, liver, and brain as
well as with bone scans. Given this, in patients who have a history
of phyllodes tumor of the breast and present with gastrointesti-
nal complaints such as obstruction or bleeding, metastatic disease
to the small bowel should be considered and abdominal imaging
obtained.
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